Monitoring of different factor VIII replacement products using a factor VIII one‐stage clotting assay on cobas t 511/711 analysers

INTRODUCTION: Recombinant coagulation factor VIII (FVIII) products are the standard of care for patients with haemophilia A. The development of modified FVIII products has provided benefit for patients but presented challenges for monitoring FVIII activity. AIM: This single‐centre study evaluated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ketteler, Carolin, Hoffmann, Ingrid, Davidson, Simon, Tiede, Andreas, Richter, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291471/
https://www.ncbi.nlm.nih.gov/pubmed/34590394
http://dx.doi.org/10.1111/hae.14416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291471/
https://www.ncbi.nlm.nih.gov/pubmed/34590394
http://dx.doi.org/10.1111/hae.14416

Ejemplares similares